PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been well-studied, according to Lewis H. Romer, MD, of Johns Hopkins University ...
AliveGen USA Inc. (AliveGen), a clinical stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ALG-801 for the ...
Background: Pulmonary arterial hypertension (PAH) poses a significant health challenge globally, with China experiencing a notable increase in its burden. Understanding the trends and factors ...